Search

Your search keyword '"HIV Fusion Inhibitors toxicity"' showing total 2 results
Start Over Descriptor "HIV Fusion Inhibitors toxicity" Topic biomimetic materials
2 results on '"HIV Fusion Inhibitors toxicity"'

1. Flexibility of small molecular CD4 mimics as HIV entry inhibitors.

Author

Kobayakawa T, Ohashi N, Hirota Y, Takahashi K, Yamada Y, Narumi T, Yoshimura K, Matsushita S, Harada S, and Tamamura H

Subjects
Binding Sites, Biomimetic Materials chemical synthesis, Biomimetic Materials chemistry, Biomimetic Materials toxicity, CD4 Antigens chemistry, Cell Line, Cell Survival drug effects, Glycine chemical synthesis, Glycine toxicity, HIV Envelope Protein gp120 chemistry, HIV Fusion Inhibitors chemical synthesis, HIV Fusion Inhibitors chemistry, HIV Fusion Inhibitors toxicity, HIV-1 chemistry, Humans, Indoles chemical synthesis, Indoles chemistry, Indoles toxicity, Molecular Docking Simulation, Pliability, Biomimetic Materials pharmacology, Glycine analogs & derivatives, Glycine pharmacology, HIV Fusion Inhibitors pharmacology, Indoles pharmacology
Abstract

CD4 mimics such as YIR-821 and its derivatives are small molecules which inhibit the interaction between the Phe43 cavity of HIV-1 gp120 with host CD4, an interaction that is involved in the entry of HIV to cells. Known CD4 mimics generally possess three structural features, an aromatic ring, an oxalamide linker and a piperidine moiety. We have shown previously that introduction of a cyclohexyl group and a guanidine group into the piperidine moiety and a fluorine atom at the meta-position of the aromatic ring leads to a significant increase in the anti-HIV activity. In the current study, the effects of conformational flexibility were investigated by introduction of an indole-type group in the junction between the oxalamide linker and the aromatic moiety or by replacement of the oxalamide linker with a glycine linker. This led to the development of compounds with high anti-HIV activity, showing the importance of the junction region for the expression of high anti-HIV activity. The present data are expected to be useful in the future design of novel CD4 mimic molecules., (Copyright © 2018. Published by Elsevier Ltd.)

Published
2018
Full Text
View/download PDF

2. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.

Author

Narumi T, Ochiai C, Yoshimura K, Harada S, Tanaka T, Nomura W, Arai H, Ozaki T, Ohashi N, Matsushita S, and Tamamura H

Subjects
Biomimetic Materials metabolism, CD4 Antigens chemistry, CD4 Antigens metabolism, Cell Line, HIV Envelope Protein gp120 chemistry, HIV Envelope Protein gp120 metabolism, HIV Fusion Inhibitors chemical synthesis, HIV Fusion Inhibitors toxicity, Humans, Piperidines chemistry, Protein Binding, Receptors, CXCR4 metabolism, Structure-Activity Relationship, Biomimetic Materials chemistry, HIV Fusion Inhibitors chemistry, Receptors, CXCR4 antagonists & inhibitors
Abstract

Small molecules behaving as CD4 mimics were previously reported as HIV-1 entry inhibitors that block the gp120-CD4 interaction and induce a conformational change in gp120, exposing its co-receptor-binding site. A structure-activity relationship (SAR) study of a series of CD4 mimic analogs was conducted to investigate the contribution from the piperidine moiety of CD4 mimic 1 to anti-HIV activity, cytotoxicity, and CD4 mimicry effects on conformational changes of gp120. In addition, several hybrid molecules based on conjugation of a CD4 mimic analog with a selective CXCR4 antagonist were also synthesized and their utility evaluated., (Copyright © 2010 Elsevier Ltd. All rights reserved.)

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results